AI assistant
Applied Therapeutics, Inc. — Director's Dealing 2021
Dec 17, 2021
34263_dirs_2021-12-16_53de89c1-fab3-4394-bd92-ebed2637645a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2021-12-14
Reporting Person: Perfetti Riccardo (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-14 | Common Stock | A | 48200 | $0.00 | Acquired | 48200 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-14 | Employee Stock Option (Right to Buy) | $9.44 | A | 32100 | Acquired | 2031-12-14 | Common Stock (32100) | Direct |
Footnotes
F1: Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on each of December 14, 2022, December 14, 2023, December 14, 2024 and December 14, 2025, subject to the Reporting Person continuing to provide services through each such date.
F2: Consists of compensatory options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on December 14, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.